Skip to Main Content

Author Details

Ralph E Coleman
Duke University School of Medicine
1974
523
98
PMIDPaper TitleJournal TitlePublished Year
25413417Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.Pract Radiat Oncol2015
24335535Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.J Neuropathol Exp Neurol2014
24819422Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET Registry.J Nucl Med2014
24578240Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.J Nucl Med2014
22633529Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.Neurobiol Aging2013
23870158Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?J Thorac Cardiovasc Surg2013
23867580High prevalence of contralateral ankle abnormalities in association with knee osteoarthritis and malalignment.Osteoarthritis Cartilage2013
23628647Does the preparation and utilization of 99mTc-sulfur colloid affect the outcomes of breast lymphoscintigraphy?J Nucl Med Technol2013
23232293Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.Radiology2013
23303962First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer.J Nucl Med2013
23375563Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.Alzheimers Dement2013
23111382Assessing the utility of the ventilation phase in ventilation-perfusion imaging for acute pulmonary embolism.Nucl Med Commun2013
22343285Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Proc Natl Acad Sci U S A2012
22691521Extrarenal retroperitoneal angiomyolipoma mimicking metastatic melanoma: CT and FDG PET correlation.Clin Nucl Med2012
22786606Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.Neurology2012
22749065Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.Lancet Neurol2012
22448033Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts.J Nucl Med2012
22282651SNM practice guideline for lung scintigraphy 4.0.J Nucl Med Technol2012
22420972Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.Int J Radiat Oncol Biol Phys2012
20675560The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.Ann Oncol2011
21799371Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions.Nucl Med Commun2011
21892055PET appearance of tuberculous empyema necessitans.Clin Nucl Med2011
21080232Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET Registry.Mol Imaging Biol2011
21245324Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.Proc Natl Acad Sci U S A2011
20856212Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.Bone Marrow Transplant2011
20102885Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease.Am J Cardiol2010
20008997PET and PET/CT reports: observations from the National Oncologic PET Registry.J Nucl Med2010
18981032Association of bone scintigraphic abnormalities with knee malalignment and pain.Ann Rheum Dis2009
19877068Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.Arthritis Rheum2009
19694582Radiation dosimetry, pharmacokinetics, and safety of ultratrace Iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid.Cancer Biother Radiopharm2009
19690042Combination of converging collimators for high-sensitivity brain SPECT.J Nucl Med2009
19555588NCCN task force: clinical utility of PET in a variety of tumor types.J Natl Compr Canc Netw2009
19016303The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.Cancer2009
19037614Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.Mol Imaging Biol2009
18077533Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.J Nucl Med2008
19088697Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors.Q J Nucl Med Mol Imaging2008
18997054Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.J Nucl Med2008
18287339A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.Neuro Oncol2008
18287273Recommendations on the use of 18F-FDG PET in oncology.J Nucl Med2008
18349396Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.J Clin Oncol2008
18403491Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.Neuro Oncol2008
18362365Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.J Clin Oncol2008
18097724Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements.Mol Imaging Biol2008
18199626A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.J Nucl Med2008
17185668Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT.Radiology2007
27157704Positron Emission Tomography Diagnosis of Alzheimer's Disease.PET Clin2007
17942807The National Oncologic PET Registry (NOPR): design and analysis plan.J Nucl Med2007
17940303Left ventricular functional assessment in mice: feasibility of high spatial and temporal resolution ECG-gated blood pool SPECT.Radiology2007
17607041The impact of urinary excretion of (18)F-labeled choline analogs.J Nucl Med2007
17545844Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.J Thorac Oncol2007
  • 1 - 50 of 523

Recommended Authors

Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Clinical Center, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 1
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 1
University of California san francisco
Career Start Year 2007
Number of shared co-authors 3
University of California san francisco
Career Start Year 2007
Number of shared co-authors 5
Clinical Center
Career Start Year 2006
Number of shared co-authors 3
University of California san francisco
Career Start Year 2005
Number of shared co-authors 3
University of Wisconsin Hospitals and Clinics
Career Start Year 1998
Number of shared co-authors 2
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Career Start Year 1998
Number of shared co-authors 10
Massachussets General Hospital, Harvard Medical School
Career Start Year 1996
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1996
Number of shared co-authors 5
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Institut Curie, PSL Research University, University Paris Saclay, Inserm LITO
Career Start Year 1993
Number of shared co-authors 1
Seattle Children's Hospital, University of Washington
Career Start Year 1993
Number of shared co-authors 1
Cleveland Clinic
Career Start Year 1992
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Keck School of Medicine of University of Southern California
Career Start Year 1990
Number of shared co-authors 14
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 1
David Geffen School of Medicine, university of california los angeles
Career Start Year 1988
Number of shared co-authors 4
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 2
University of Iowa
Career Start Year 1986
Number of shared co-authors 3
Massachusetts General Hospital
Career Start Year 1984
Number of shared co-authors 0
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 1
University of Washington
Career Start Year 1980
Number of shared co-authors 3
University of California Los Angeles David Geffen School of Medicine
Career Start Year 1976
Number of shared co-authors 2
Gordon Center for Medical Imaging, Massachusetts General Hospital
Career Start Year 1974
Number of shared co-authors 6
David Geffen School of Medicine at university of california los angeles
Career Start Year 1964
Number of shared co-authors 2

Collaborators

Duke University Medical Center
Co-authored papers 24
Co-authored papers 23
Co-authored papers 21
Duke University Medical Center
Co-authored papers 17
Co-authored papers 14
Duke University Medical Center
Co-authored papers 9
Duke University School of Medicine
Co-authored papers 8
Mallinckrodt Institute of Radiology , Washington University School of Medicine
Co-authored papers 6
Premier Research Institute and NOVA SE University
Co-authored papers 6
Banner Alzheimer's Institute
Co-authored papers 6
Wake Forest University School of Medicine
Co-authored papers 6
Barrow Neurological Institute
Co-authored papers 6
Banner Alzheimer's Institute, University of California
Co-authored papers 6
From the National Institutes of Health
Co-authored papers 5
Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 4
Co-authored papers 4
Brigham and Women's Hospital, Massachusetts General Hospital
Co-authored papers 4
Duke University Medical Center
Co-authored papers 4
Co-authored papers 4
Homer Stryker MD School of Medicine, Western Michigan University
Co-authored papers 4
Co-authored papers 4
Medical College of Georgia
Co-authored papers 4
Co-authored papers 4
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 3
Duke University
Co-authored papers 3
Vanderbilt University School of Medicine
Co-authored papers 3
Duke University
Co-authored papers 3
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers 3
Duke University
Co-authored papers 2
Co-authored papers 2